ADVA
11.5.2022 09:02:09 CEST | Business Wire | Press release
ADVA (FSE: ADV) today announced that Westfalen Weser Netz has deployed its ALM fiber monitoring technology for precise, real-time insight into its regional metro network. The solution gives the municipal utility provider complete infrastructure assurance. Now it can instantly detect and rapidly repair fiber breaks with minimal disruption. The ADVA ALM enables Westfalen Weser Netz to dramatically shorten repair cycles and enhance network performance. It also means far fewer truck rolls and significant savings on fuel cost. The technology integrated seamlessly into Westfalen Weser Netz’s cableScout® management software provided by ADVA’s partner JO Software Engineering GmbH.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220510005843/en/
“The ADVA ALM is helping us ensure excellent network availability while also reducing maintenance effort and expense. It gives our repair teams the power to remotely measure attenuation and quickly locate any degradation in our fiber plant. They can then take action straightaway to resolve problems,” said Stefan Kenneweg, consultant at Westfalen Weser Netz. “Combining the ADVA ALM assurance solution with our cableScout® management software is like turning on the lights right across our network. Now there are no more blind spots. That means no more wasted hours on false alarms and no nasty surprises for our customers.”
The ADVA ALM is now delivering passive, in-service monitoring of Westfalen Weser Netz’s fiber links. The simple, plug-and-play device offers several key advantages for utility network assurance. Its fanless operation and compact, low-energy design reduce opex and environmental impact. It’s also a highly robust solution ready to be installed in almost any location. Built on standardized, open management interfaces, the ADVA ALM is fully interoperable with Westfalen Weser Netz’s existing cableScout® software. This provides a geographic information system (GIS) to quickly and easily locate failures.
“Our ALM fiber monitoring platform is already bringing major benefits to Westfalen Weser Netz and its customers, helping the company reduce truck rolls and maximize resource efficiency. There really is no technology that has this much impact with such little cost and effort,” commented Hartmut Müller-Leitloff, SVP of sales, EMEA at ADVA. “When it comes to providing homes and businesses with safe, efficient and sustainable electricity, gas and water, the reliability of the data transport network is crucial. Now that Westfalen Weser Netz has total visibility and control of its fiber infrastructure, it can avoid outages and introduce new services with confidence.”
“Our cableScout® platform combined with the ADVA ALM solution for in-service monitoring provides Westfalen Weser Netz with continual access to a detailed layout of its network. Its team now has comprehensive understanding of the complete fiber architecture, enabling efficient end-to-end planning, management and troubleshooting,” said Ralph Kosztovits, managing partner at JO Software Engineering GmbH. “ADVA is a company that shares our commitment to sustainable growth and creating new opportunities through innovation. Our close alliance offers major benefits for network operators like Westfalen Weser Netz who are committed to empowering customers to achieve more and enhancing end user experience.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .
Published by:
ADVA Optical Networking SE, Munich, Germany
View source version on businesswire.com: https://www.businesswire.com/news/home/20220510005843/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Duco Launches the First Agentic Operations Platform for Financial Services27.5.2026 09:20:00 CEST | Press release
Duco, today launched the first agentic Operations platform for financial services. Built on the engine that already processes 20 billion transactions every month for more than 200 clients, including seven of the top 20 banks and ten of the top 20 asset managers, the platform brings together everything firms need to run post-trade Operations alongside autonomous agents, safely and at scale. The launch establishes a breakthrough the industry has been waiting for. A tool surface, purpose-built for agents. Duco has unbundled its platform into a new alternative agent layer that reconfigures its platform into hundreds of discrete capabilities servicing post trade. Model Context Protocol (MCP) gives capabilities covering reconciliation, data preparation, data access, audit trails, exception management, document creation and more. For the first time, agents have a verified, deterministic toolset built specifically for post-trade. Agents do not replace matching, rules or audit; they use them. P
Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)27.5.2026 08:49:00 CEST | Press release
STC-1010 is a first-in-class allogeneic in vivo immunotherapy for which the FDA has authorized clinical evaluation in the U.S. under the BreAK-CRC001 study. This strategic milestone enables the company to execute a global clinical strategy following European regulatory approvals (ANSM, AFMPS), first patients dosed with preliminary results and good tolerability observed in early Phase Ia. First data are expected to be presented during ESMO annual congress 2026. Brenus Pharma, a clinical stage biotechnology company developing novel in vivo immunotherapies for solid tumors, announced that the U.S. Food and Drug Administration (FDA) has accept the company's Investigational New Drug (IND) application for its first drug candidate, STC-1010, in microsatellite stable (MSS) metastatic colorectal cancer (mCRC). STC-1010 is designed to address a critical unmet need worldwide. Approximately 95% of mCRC patients have MSS tumors, which demonstrate minimal response to standard immunotherapies. The FD
Tide Crosses 2 Million Members Worldwide - Big Step Forward in Mission to Support and Grow Small Businesses27.5.2026 08:00:00 CEST | Press release
Continuing to grow in the UK and internationally, with India seeing especially strong member growth in the last 12 months In the UK, Tide has 15% market share and has helped small businesses access over £1.75bn in credit Rapid roll out of products; from admin, accounting and tax tools; subscription options; payment solutions; government registrations; bill payments and credit Tide, the UK’s leading business management platform, today announces it has crossed 2 million members globally, with India in particular seeing strong growth. More than 1.1 million small businesses joined Tide in India since the company launched there in December 2022. This makes India Tide’s fastest-growing market by member acquisition. The UK is Tide’s home market, with 900,000 SMEs, 15% market share, and the majority of the company’s revenue. Tide’s steadily expanding its presence in Europe, with Germany and France, where the platform is gaining strong traction, thanks to millions of small businesses turning to
Alfasigma presents first data on filgotinib from the Phase 3 OLINGUITO trial in axial spondyloarthritis at EULAR 202627.5.2026 08:00:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific and investor media only.In the OLINGUITO Phase 3 study in radiographic (r) and non-radiographic (nr) axial spondyloarthritis (axSpA) a significantly greater proportion of patients achieved the prespecified primary endpoint of ASAS40 with filgotinib compared with placebo at week 16.The improvements in signs and symptoms of axSpA with filgotinib, an oral, once-daily JAK1 preferential inhibitor, were observed as early as week 1 and maintained over 52 weeks of treatment.In the r-axSpA and nr-axSpA filgotinib groups, of those achieving a response in the prespecified primary endpoint of ASAS40 at week 16, 84.6% and 78.0% maintained their responses to week 52, respectively.In OLINGUITO no new safety signals were observedfor filgotinib over 52 weeks, and the safety profile was consistent with the known overall safety profile.Primary results from the Phase 3 OLINGUITO tria
Royal London Asset Management Expands Relationship with SS&C to Service New Australian Funds27.5.2026 00:00:00 CEST | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that Royal London Asset Management, a leading U.K. fund management company, has extended its relationship with SS&C. SS&C Global Investor & Distribution Solutions will provide fund administration and unit registry services for its new range of Australian active funds, including: Royal London Global Equity Diversified Fund Royal London Global Equity Enhanced Fund Royal London Global Equity Select Fund Royal London Short Duration Global High Yield Bond Fund RLAM is part of Royal London, the U.K.’s largest mutual life, pensions and investment company. SS&C services approximately £72bn in assets under management across its U.K. fund range. Equity Trustees will serve as the Responsible Entity for RLAM’s new funds, which have launched with around AUD $1 billion in AUM. The unit trusts are structured as feeder funds, providing investors with indirect exposure to RLAM’s range of Dublin-domiciled Undertakings for Collective Investm
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom